Under what circumstances will lung cancer affect the eyes

Lung cancer is the most common malignant tumor in the respiratory system, which is very harmful to the patient's health. Comprehensive measures need to be taken according to the patient's specific situation. Common pathological types include squamous cell carcinoma, adenocarcinoma and small cell lung cancer. Lung cancer is the most common malignant tumor in the respiratory system, which is very harmful to the patient's health. Comprehensive measures need to be taken according to the patient's specific situation. Common pathological types include squamous cell carcinoma, adenocarcinoma and small cell lung cancer. If the patient has brain metastasis of lung cancer.

Can allergic rhinitis cause lung cancer?

There is no clear relationship between allergic rhinitis and lung cancer. The clinical analysis is as follows: The occurrence of allergic rhinitis is mainly caused by the inhalation of allergens into the nasal cavity. Clinically, there are mainly related symptoms such as sneezing, runny nose, and nasal itching. If it is not treated for a long time, it may induce asthma, such as repeated coughing, asthma, chest tightness, shortness of breath and other related symptoms, but in any case, these diseases are benign, not malignant diseases, and there is no possibility of malignant changes. Although the cause of pneumonia is not yet fully understood, it is believed to be closely related to smoking, electrical radiation, air pollution and genetic factors. Allergic rhinitis does not usually lead to lung cancer.

What is the 5-year survival rate for advanced lung cancer?

In the past, people believed that the survival period of advanced lung cancer was short, with a five-year survival rate of zero. However, with the diversification of treatment methods, the development of science and technology, and the improvement of the effects and control of lesions with new drugs and new treatments, the survival rate of patients with gene mutations can be improved. The five-year survival rate of patients with targeted therapy exceeds 10%. Many advanced patients live for five years, and some live for ten years. Tumor metastasis and recurrence account for about 80% of radical treatments in 3 and 10 years. Advanced cancer patients may survive for five years.